P-605 Symptom relief and quality of life (COL) in PS2 patients withnon-small cell lung cancer (NSCLC) subsequent to treatment with paclitaxel poliglumex (XYOTAXT™): Phase 3 trial results
Cella, D., Cashy, J.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)81098-0
Date:
July, 2005
File:
PDF, 290 KB
english, 2005